← Leaderboards
Sara A Courtneidge
Van Andel Research Institute
$12,091,658
Attributed
$12,091,658
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,091,658 · 11
By mechanism
R01$10,282,370 · 6
P30$1,437,843 · 3
R21$368,445 · 1
R13$3,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsCellsCancer CellNeoplasm MetastasisMemberSignal TransductionTumor GrowthGrowthTumor ProgressionInhibitor/AntagonistBaseNeoplastic CellMediatingExtracellular MatrixSmall MoleculeAngiogenesisCancer TherapyPropertyCancer Center Support GrantFundingIn VivoLeadProteolysis
Grant awards (50)
Validating and Characterizing a New Melanoma Therapeutic Target$636,343
R01 · FY2020 · CA · contact PI
Validating and Characterizing a New Melanoma Therapeutic Target$616,207
R01 · FY2019 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$42,241
P30 · FY2019 · CA · contact PI
Validating and Characterizing a New Melanoma Therapeutic Target$635,068
R01 · FY2018 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$42,241
P30 · FY2018 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$12,439
P30 · FY2018 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$9,140
P30 · FY2018 · CA · contact PI
Validating and Characterizing a New Melanoma Therapeutic Target$646,803
R01 · FY2017 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$42,239
P30 · FY2017 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$42,239
P30 · FY2016 · CA · contact PI
Kinases as therapeutic targets for cancer progression$319,550
R01 · FY2015 · CA · contact PI
Src, p53 and estrogen receptor-positive breast cancer$200,970
R21 · FY2015 · CA · contact PI
Program 3 - Tumor Microenvironment and Metastasis$42,239
P30 · FY2015 · CA · contact PI
Kinases as therapeutic targets for cancer progression$275,486
R01 · FY2014 · CA · contact PI
PROGRAM LEADERS$170,031
P30 · FY2014 · CA · contact PI
Src, p53 and estrogen receptor-positive breast cancer$167,475
R21 · FY2014 · CA · contact PI
TUMOR MICROENVIRONMENT$108,876
P30 · FY2014 · CA · contact PI
Kinases as therapeutic targets for cancer progression$92,400
R01 · FY2014 · CA · contact PI
Kinases as therapeutic targets for cancer progression$380,348
R01 · FY2013 · CA · contact PI
PROGRAM LEADERS$198,253
P30 · FY2013 · CA · contact PI
TUMOR MICROENVIRONMENT$183,599
P30 · FY2013 · CA · contact PI
Kinases as therapeutic targets for cancer progression$396,325
R01 · FY2012 · CA · contact PI
Generation and utility of NADPH oxidase inhibitors$384,435
R01 · FY2012 · CA · contact PI
PROGRAM LEADERS$184,358
P30 · FY2012 · CA · contact PI
TUMOR MICROENVIRONMENT$120,128
P30 · FY2012 · CA · contact PI
PROGRAM LEADERS$7,940
P30 · FY2012 · CA · contact PI
TUMOR MICROENVIRONMENT$7,940
P30 · FY2012 · CA · contact PI
Kinases as therapeutic targets for cancer progression$396,325
R01 · FY2011 · CA · contact PI
Generation and utility of NADPH oxidase inhibitors$384,435
R01 · FY2011 · CA · contact PI
Reactive Oxygen Species and Cancer Cell Invasion$352,013
R01 · FY2011 · CA · contact PI
PROGRAM LEADERS$86,138
P30 · FY2011 · CA · contact PI
TUMOR MICROENVIRONMENT$21,615
P30 · FY2011 · CA · contact PI
High Throughput Microscopy Assays to Identify Inhibitors of Metastasis$396,325
R01 · FY2010 · CA · contact PI
Generation and utility of NADPH oxidase inhibitors$396,325
R01 · FY2010 · CA · contact PI
Reactive Oxygen Species and Cancer Cell Invasion$362,900
R01 · FY2010 · CA · contact PI
PROGRAM LEADERS$92,675
P30 · FY2010 · CA · contact PI
TUMOR MICROENVIRONMENT$23,512
P30 · FY2010 · CA · contact PI
High Throughput Microscopy Assays to Identify Inhibitors of Metastasis$396,325
R01 · FY2009 · CA · contact PI
Reactive Oxygen Species and Cancer Cell Invasion$362,900
R01 · FY2009 · CA · contact PI
High Throughput Microscopy Assays to Identify Inhibitors of Metastasis$396,325
R01 · FY2008 · CA · contact PI
Reactive Oxygen Species and Cancer Cell Invasion$362,900
R01 · FY2008 · CA · contact PI
Biological and genetic analysis of Fish, a Src substrate$334,133
R01 · FY2008 · CA · contact PI
Reactive Oxygen Species and Cancer Cell Invasion$362,900
R01 · FY2007 · CA · contact PI
Biological and genetic analysis of Fish, a Src substrate$321,798
R01 · FY2007 · CA · contact PI
Biological and genetic analysis of Fish, a Src substrate$341,802
R01 · FY2006 · CA · contact PI
Biological and genetic analysis of Fish, a Src substrate$266,403
R01 · FY2005 · CA
Biological and genetic analysis of Fish, a Src substrate$84,142
R01 · FY2005 · CA
Conference on Molecular Targets for Cancer Therapy$3,000
R13 · FY2005 · CA
Biological and genetic analysis of Fish, a Src substrate$335,790
R01 · FY2004 · CA
Biological and genetic analysis of Fish, a Src substrate$45,664
R01 · FY2004 · CA